Does RUCAPARIB CAMSYLATE Cause Dysgeusia? 558 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 558 reports of Dysgeusia have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 6.8% of all adverse event reports for RUCAPARIB CAMSYLATE.
558
Reports of Dysgeusia with RUCAPARIB CAMSYLATE
6.8%
of all RUCAPARIB CAMSYLATE reports
8
Deaths
86
Hospitalizations
How Dangerous Is Dysgeusia From RUCAPARIB CAMSYLATE?
Of the 558 reports, 8 (1.4%) resulted in death, 86 (15.4%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Dysgeusia Listed in the Official Label?
Yes, Dysgeusia is listed as a known adverse reaction in the official FDA drug label for RUCAPARIB CAMSYLATE.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Dysgeusia?
NIRMATRELVIR\RITONAVIR (7,381)
SUNITINIB MALATE (1,226)
SODIUM (1,216)
LENALIDOMIDE (1,180)
LIFITEGRAST (1,067)
CABOZANTINIB S-MALATE (777)
CLARITHROMYCIN (717)
VISMODEGIB (706)
ADALIMUMAB (674)
PALBOCICLIB (620)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Dysgeusia Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE